1. Home
  2. LGL vs QNCX Comparison

LGL vs QNCX Comparison

Compare LGL & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • QNCX
  • Stock Information
  • Founded
  • LGL 1917
  • QNCX 2012
  • Country
  • LGL United States
  • QNCX United States
  • Employees
  • LGL N/A
  • QNCX N/A
  • Industry
  • LGL Industrial Machinery/Components
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LGL Technology
  • QNCX Health Care
  • Exchange
  • LGL Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • LGL 32.4M
  • QNCX 34.4M
  • IPO Year
  • LGL N/A
  • QNCX 2019
  • Fundamental
  • Price
  • LGL $6.12
  • QNCX $1.71
  • Analyst Decision
  • LGL
  • QNCX Strong Buy
  • Analyst Count
  • LGL 0
  • QNCX 3
  • Target Price
  • LGL N/A
  • QNCX $9.67
  • AVG Volume (30 Days)
  • LGL 4.9K
  • QNCX 1.4M
  • Earning Date
  • LGL 11-19-2024
  • QNCX 11-19-2024
  • Dividend Yield
  • LGL N/A
  • QNCX N/A
  • EPS Growth
  • LGL N/A
  • QNCX N/A
  • EPS
  • LGL 0.07
  • QNCX N/A
  • Revenue
  • LGL $3,929,000.00
  • QNCX N/A
  • Revenue This Year
  • LGL N/A
  • QNCX N/A
  • Revenue Next Year
  • LGL N/A
  • QNCX N/A
  • P/E Ratio
  • LGL $78.69
  • QNCX N/A
  • Revenue Growth
  • LGL 599.11
  • QNCX N/A
  • 52 Week Low
  • LGL $4.42
  • QNCX $0.51
  • 52 Week High
  • LGL $6.76
  • QNCX $1.79
  • Technical
  • Relative Strength Index (RSI)
  • LGL 54.82
  • QNCX 67.33
  • Support Level
  • LGL $5.85
  • QNCX $0.75
  • Resistance Level
  • LGL $6.21
  • QNCX $1.76
  • Average True Range (ATR)
  • LGL 0.24
  • QNCX 0.25
  • MACD
  • LGL 0.01
  • QNCX 0.03
  • Stochastic Oscillator
  • LGL 72.92
  • QNCX 78.76

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: